| scholarly article | Q13442814 |
| P50 | author | Sergio Serrano-Villar | Q42234516 |
| Vicente Estrada | Q60731293 | ||
| Manuel Enrique Fuentes Ferrer | Q64211885 | ||
| Carolina Sanchez Marcos | Q96241102 | ||
| P2093 | author name string | A Fernández-Cruz | |
| M Avila | |||
| N G P de Villar | |||
| S Moreno | |||
| T Sainz | |||
| P2860 | cites work | Immune activation and inflammation in HIV-1 infection: causes and consequences | Q22252860 |
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| Inflamm-aging. An evolutionary perspective on immunosenescence | Q28141817 | ||
| Epidemiology of sarcopenia among the elderly in New Mexico | Q28268502 | ||
| Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease | Q33528999 | ||
| Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions | Q33756494 | ||
| Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection | Q33857515 | ||
| Kidney function and the risk of cardiovascular events in HIV-1-infected patients | Q33880428 | ||
| Expert consensus document on arterial stiffness: methodological issues and clinical applications | Q33999785 | ||
| Th17, gut, and HIV: therapeutic implications | Q34050602 | ||
| HIV Infection, Inflammation, Immunosenescence, and Aging | Q34150710 | ||
| Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data | Q34249847 | ||
| Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly | Q34491109 | ||
| Markers of atherosclerosis and inflammation and mortality in patients with HIV infection | Q34554934 | ||
| Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis | Q34604937 | ||
| T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women | Q34764361 | ||
| Changes in the risk of death after HIV seroconversion compared with mortality in the general population | Q34791057 | ||
| Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. | Q36654798 | ||
| Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases | Q36743092 | ||
| The role of HIV in serious diseases other than AIDS. | Q37186467 | ||
| Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis | Q37215251 | ||
| HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity | Q37378238 | ||
| The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults | Q42273640 | ||
| Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses | Q43717389 | ||
| Augmentation index is associated with cardiovascular risk | Q44243476 | ||
| The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression | Q44701988 | ||
| Sarcopenia: alternative definitions and associations with lower extremity function | Q47306900 | ||
| Survival of persons with and without HIV infection in Denmark, 1995-2005. | Q50544706 | ||
| Differences according to gender and health status in CD4:CD8 ratio in a sample of community-dwelling oldest old. The OCTABAIX immune study. | Q50780545 | ||
| HIV Replication and Immune Status Are Independent Predictors of the Risk of Myocardial Infarction in HIV-Infected Individuals | Q56837760 | ||
| An Immune Risk Phenotype, Cognitive Impairment, and Survival in Very Late Life: Impact of Allostatic Load in Swedish Octogenarian and Nonagenarian Humans | Q56986846 | ||
| Incipient Renal Impairment as a Predictor of Subclinical Atherosclerosis in HIV-Infected Patients | Q59118572 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| P304 | page(s) | 40-49 | |
| P577 | publication date | 2013-09-06 | |
| P1433 | published in | HIV Medicine | Q15756376 |
| P1476 | title | The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery | |
| P478 | volume | 15 |
| Q36259851 | A Low Peripheral Blood CD4/CD8 Ratio Is Associated with Pulmonary Emphysema in HIV. |
| Q40463006 | A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication. |
| Q35814594 | Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study |
| Q30807586 | Assessing the role of peripheral CD8 T cells in neurocognitive impairment in HIV-infected men who have sex with men: data from the MSM Neurocog Study. |
| Q57132186 | Blood pressure responses after resistance exercise session in women living with human immunodeficiency virus/acquired immunodeficiency syndrome |
| Q36671999 | CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy |
| Q37364956 | CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART. |
| Q39946507 | CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study |
| Q40971969 | CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study |
| Q40043083 | CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC). |
| Q40294920 | CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy |
| Q33591190 | Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets |
| Q91972986 | Correlation of CD4/CD8 Ratio with Carotid Intima-Media Layer Thickness in HIV/AIDS Patients at Sanglah General Hospital, Bali, Indonesia |
| Q61873151 | Cytokine secretion responsiveness of lymphomonocytes following cortisol cell exposure: Sex differences |
| Q63683189 | Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy |
| Q40779840 | Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression |
| Q40531468 | Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients |
| Q33618542 | HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality |
| Q47141455 | Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health? |
| Q92689080 | Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2) |
| Q33919900 | Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial |
| Q33637866 | Impact of illicit opioid use on T cell subsets among HIV-infected adults |
| Q37534052 | Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio. |
| Q41454338 | Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity |
| Q49904882 | Indications for starting ART. |
| Q59350489 | Low CD4/CD8 Ratio in Classical Swine Fever Postnatal Persistent Infection Generated at three weeks after birth |
| Q30426598 | Magnetographic array for the capture and enumeration of single cells and cell pairs |
| Q50087578 | Mechanisms of CD8+ T cell-mediated suppression of HIV/SIV replication. |
| Q64245066 | Middle-Aged Men With HIV Have Diminished Accelerometry-Based Activity Profiles Despite Similar Lab-Measured Gait Speed: Pilot Study |
| Q59118545 | Monitoring the CD4/CD8 ratio: a promising indicator of disease progression in HIV-infected individuals? |
| Q36072424 | Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid. |
| Q40070123 | Peripheral immunophenotype and viral promoter variants during the asymptomatic phase of feline immunodeficiency virus infection |
| Q40989476 | Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy |
| Q93270645 | Sarcopenia in people living with the Human Immunodeficiency Virus: a systematic review and meta-analysis |
| Q61797436 | Suboptimal Immune Reconstitution among HIV-Infected Saudi Patients following Successful Antiretroviral Treatment |
| Q57456060 | Successful lung transplantation in an HIV seropositive patient with desquamative interstitial pneumonia: a case report |
| Q64243761 | The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV |
| Q39093640 | Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects. |
| Q40932221 | Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation. |
Search more.